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A B S T R A C T   
Premature birth is the primary risk factor in neonatal deaths, with the majority of extremely premature babies 
cared for in neonatal intensive care units (NICUs). Mortality risk prediction in this setting can greatly improve 
patient outcomes and resource utilization. However, existing schemes often require laborious medical testing and 
calculation, and are typically only calculated once at admission. In this work, we propose a shallow hybrid neural 
network for the prediction of mortality risk in 3-day, 7-day, and 14-day risk windows using only birthweight, 
gestational age, sex, and heart rate (HR) and respiratory rate (RR) information from a 12-h window. As such, this 
scheme is capable of continuously updating mortality risk assessment, enabling analysis of health trends and 
responses to treatment. The highest performing scheme was the network that considered mortality risk within 3 
days, with this scheme outperforming state-of-the-art works in the literature and achieving an area under the 
receiver-operator curve (AUROC) of 0.9336 with standard deviation of 0.0337 across 5 folds of cross-validation. 
As such, we conclude that our proposed scheme could readily be used for continuously-updating mortality risk 
prediction in NICU environments.   
1. Introduction 
Complications resulting from premature birth are the leading cause 
of death in children under 5 [1], and over 50% of neonatal deaths occur 
in preterm infants [2]. Child deaths due to preterm birth are in excess of 
1.1 million per year globally [3]. Recent data shows that preterm birth 
rates are increasing in 62 of the 65 countries with reliable trend data, 
indicating that this is a growing problem throughout the world. 
Preterm infants are regularly cared for in Neonatal Intensive Care 
Units (NICUs). A recent study in the United States found that 84.41% of 
very low birthweight infants (those weighing 500–1499 g) and 41.18% 
of low birthweight infants (those weighing 1500–2499 g) are admitted 
to NICU, respectively [4]. In the NICU, assessment of mortality risk as-
sists medical specialists in making difficult decisions regarding which 
treatments should be used and when, and whether initiated treatments 
are working effectively. It has been identified that precise mortality 
prediction would ease the process of making such decisions [5]. 
Currently, there are several scoring schemes used in NICUs for 
mortality risk assessment. One commonly used score is the updated 
Clinical Risk Index for Babies (CRIB-II) [6], which is a recalibrated and 
simplified iteration of the original CRIB score [7]. Another family of 
scores that are routinely used are the Score for Neonatal Acute Physi-
ology (SNAP) [8] and it’s derivatives, which include the expanded SNAP 
Perinatal Expansion (SNAPPE) [9], and the simplified versions of 
SNAP-II and SNAPPE-II [10]. The Berlin score [11] and Neonatal Mor-
tality Prognostic Index (NMPI) [12] are also used, albeit to a lesser 
extent. 
There are several limitations with the existing scores. Firstly, all 
aforementioned scores include parameters that require complex manual 
measurement. Additionally, the scores were all developed over 15 years 
ago. A recent review of the existing scoring systems has identified the 
need for updated and enhanced scores based on more recent cohorts 
[13]. This is further highlighted by a recent study [14], which found that 
the SNAPPE-II score achieved a significantly lower area under the 
receiver-operator curve (AUROC) of 0.849 on babies admitted between 
2012 and 2013 compared to the AUROC of 0.92 when SNAPPE-II was 
proposed in 2001 [10]. Similarly, a recent paper [5] found that CRIB-II 
achieved AUROCs of 0.667 and 0.708 for mortality cases in ≤7 days and 
>7 days, respectively, on babies admitted between 2001 and 2011 - a 
drastic decrease from the AUROC of 0.92 reported in the 2003 paper that 
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proposed CRIB-II [6]. 
With recent studies identifying the weaknesses of existing scores, 
there has been some renewed interest in developing updated neonatal 
mortality risk scores using new techniques, however this field is in its 
infancy. Several studies have investigated techniques including logistic 
regression [15,16], densely-connected neural networks [17], random 
forest [18], and fusion of multiple machine learning algorithms into a 
super learner [19]. Of these, the highest performing schemes in terms of 
AUROC were those that used neural network techniques [17,19] and 
random forest [18]. 
The literature on predicting adult mortality is far more extensive, 
and many studies have investigated machine learning for prediction of 
mortality in adult ICU [20–27], with most achieving reasonable ability 
to distinguish between mortality and non-mortality. Of particular in-
terest are long short-term memory (LSTM) neural networks, which were 
identified to be suitable for mortality prediction and the related problem 
of sepsis prediction in several works [20,27,28]. One recent work [22] 
also investigated the combination of convolutional neural network 
(CNN) layers with LSTM layers, achieving an AUROC of 0.836 using 48 h 
of laboratory and vital sign data. In our own previous work, we devel-
oped a scheme for adult mortality risk assessment in intensive care using 
features based on basic demographics and variations in heart rate, res-
piratory rate, blood pressure, blood oxygen saturation and temperature 
as inputs to a CNN-LSTM neural network, with significant success [29]. 
Much of the adult mortality literature is relevant to neonatal mortality, 
as similar strategies and variables can be used to develop machine 
learning approaches for prediction of mortality on the neonatal cohort. 
A recurring limitation in much of the literature for mortality pre-
diction is the selection of variables that are tedious or difficult to mea-
sure regularly. Such parameters include extensive laboratory results 
[19], maternal characteristics [15,17], and existing conditions [17,19]. 
This limits the usefulness of such schemes, as often the acquisition of 
these parameters would increase the burden on neonatal healthcare 
staff. Conversely, several other studies were limited by their selection of 
variables that do not change - such as the scheme that considered 
pre-birth and start-of-labour characteristics [15] and the scheme that 
used birthweight, blood oxygen at admission, and respiratory support 
within the first 24 h from birth [16]. This prevents recalculation of the 
infant’s risk on a continuous or ongoing basis, and does not allow for 
assessment of response to treatments. 
An ideal mortality risk prediction scheme would be one that uses 
fundamental demographics and routinely measured parameters to pro-
vide continuous mortality risk assessment, allowing for assessment of 
changing risk throughout the NICU stay without placing unreasonable 
additional burden on NICU staff. 
As such, this paper proposes the Neonatal Artificial Intelligence 
Mortality Score (NAIMS), a hybrid CNN-LSTM neural network that relies 
on simple demographics and trends in heart and respiratory rate to 
determine mortality risk in the NICU for short- and long-term risk 
windows. Using 12 h of data from any window, NAIMS shows strong 
performance in predicting an infant’s risk of mortality within 3, 7, or 14 
days. This is the first known work to consider only basic demographics 
along with respiratory rate and heart rate statistics to produce an ac-
curate prediction of immediate mortality risk. This scheme would pro-
vide rapid assessment of mortality risk in several risk windows, with no 
need for invasive procedures or knowledge of medical histories. Due to 
the simplicity and high performance of our proposed scheme, NAIMS 
could readily be continuously and automatically recalculated, enabling 
analysis of a NICU baby’s responsiveness to treatment and other health 
trends. To the best of the authors’ knowledge, NAIMS is the first scheme 
to utilize a hybrid CNN-LSTM network to predict neonatal mortality 
from demographics and vital signs. 
2. Methodology 
2.1. Data selection 
The data used in this study was obtained from the Medical Infor-
mation Mart for Intensive Care (MIMIC-III) clinical database [30]. This 
database includes records from 7870 neonates admitted between 2001 
and 2008. As this study focuses on all infants admitted to the NICU for 
any reason, the criterion used to select patients was that the first care 
unit was the NICU. No exclusions were made based on birthweight, 
gestational age, or any other factors. 
At this stage, the length of stay for the mortality cases was evaluated 
to determine the most useful windows for mortality prediction. It was 
found that the average length of stay (LOS) was 8.08 days with a high 
standard deviation (SD) of 16.75 days across the overall patient cohort. 
However, LOS was lower amongst the mortality subset of the cohort, 
with a mean of 4.66 days and SD of 5.58 days. The full distribution of 
LOS within the database is illustrated by the boxplots in Fig. 1. 
The distribution of LOS, clustered around the lower end, served as 
our motivation for considering several risk windows of varying lengths, 
namely 3-day, 7-day, and 14-day windows. These windows were also 
utilized in our previous work [29] with high success, further supporting 
the use of these windows in this work. Assessment of mortality risk 
within these three windows would enable assessment of immediate risk, 
as well as longer-term survival prospects. As this model can be recal-
culated regularly throughout the stay, it is also suitable for the outlier 
cases with extremely long LOS values. 
Given our largest window of interest is 14 days, we acquired 14 days 
of data for each patient. If the NICU stay exceeded 14 days, the first 14 
days were obtained for non-mortality cases, while the 14 days prior to 
death time were used for the mortality cases. Where any patient stay was 
less than 14 days, all data from NICU admission to discharge or death 
were obtained. 
Information obtained from this database included gestational age, 
birthweight, sex, time of death (where applicable) and available chart 
events for respiratory rate (RR) and heart rate (HR). No further de-
mographic, health, or other factors were considered, as our aim was to 
develop a tool that could be applied with minimal prior knowledge of 
the patient. Maternal characteristics were also not considered. Feature 
selection was then performed, as discussed in the following subsection. 
2.2. Feature selection 
In selecting features for our proposed NAIMS scheme, there were 
several major considerations. Firstly, to prevent placing additional 
burden on healthcare staff, we determined that features must be based 
on parameters that are easy to measure. Ideally, dynamic parameters 
would also be able to be measured automatically. Secondly, we selected 
features based on recent findings in the literature. 
Demographics features that describe fundamental information about 
the patient were selected - namely birthweight, gestational age, and sex. 
Birthweight and gestational age have repeatedly been shown in the 
literature to be strong indicators of mortality risk, and have been used by 
most existing schemes in the literature for this reason. Birthweight is a 
static variable, and thus the first birthweight in the patient’s record was 
used. For most patients, gestational age was recorded in MIMIC-III as a 
range (e.g. 26-28 weeks). As such, we took the mean of the provided age 
range to be the gestational age. Where the infant was older than 40 
weeks, their gestational age was recorded as “40” in MIMIC-III; we thus 
took this age group as simply 40. 
Sex has also been used as it has been long known that physiological 
differences between the sexes lead to differing normal ranges for vital 
signs [31]. In our preprocessing, we set babies’ sex to ‘1’ or ‘0’, corre-
sponding to the ‘F’ or ‘M’ classification in MIMIC-III, respectively. 
Next, we selected commonly recorded parameters in the NICU. A 
recent comprehensive review paper [32] concluded that the current 
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techniques of intermittent vital sign measurement fail to capture health 
trends, and that continuous analysis of vital sign trends would likely 
improve outcomes for NICU patients. Another work [33] identified that 
short-term variability of heart rate (HR) and respiratory rate (RR) are 
strong predictors of high morbidity. As such, we chose to focus on HR 
and RR in this work. These two metrics are readily available in the 
MIMIC-III database, indicating that they are currently recorded 
routinely and readily in NICU environments. 
To capture information about the trends in these two vital signs, we 
selected a 12-h period at the beginning of the relevant risk window. All 
HRs and RRs during this 12-h window were recorded, provided that they 
were greater than zero to eliminate flat-line cases and impossible 
negative values. Statistical analysis was then applied to quantify the 
variation of each vital sign during the 12-h window. 
For both HR and RR, the first value, last value, minimum value, 
maximum value, mean value, median value, and standard deviation was 
calculated for inclusion in the feature vector. The first and last values 
were chosen as these can highlight major changes in the vital sign during 
the 12-h window. Minimum and maximum are used to show the most 
extreme values during the considered window. To represent the average 
vital sign, both mean and median were recorded. While mean is typically 
more useful, median is helpful in the case where there are significant 
outliers. Finally, the standard deviation is used as it is a strong indicator 
of variability. Where either HR or RR measurements were completely 
absent from a patient’s record, that record was discarded and not used 
for training or testing. 
The final feature array was as follows: birthweight, gestational age, sex, 
first value for HR, last value for HR, minimum HR, maximum HR, mean HR, 
median HR, standard deviation of HR, first value for RR, last value for RR, 
minimum RR, maximum RR, mean RR, median RR, and standard deviation 
of RR. The majority of these features were continuous, with the excep-
tion of sex which was binary and gestational age which was categorized 
into discrete bins in the database. 
These features were calculated from the first 12 h for each of the 
considered risk windows; 3-day, 7-day, and 14-day. Cohorts varied in 
size for each considered risk window, due to differing levels of miss-
ingness in the data for different windows. 
2.3. Balancing the dataset 
Following data and feature selection, it was clear that the data was 
strongly unbalanced. In the cohort that met all criteria for inclusion in 
training and testing the 3-day NAIMS scheme, only 1.02% of the 2751 
cases ended in mortality. Similarly, for 7-day and 14-day NAIMS, the 
mortality rates were 1.02% of 2751 cases and 1.09% of 2753 cases, 
respectively. The level of imbalance can create significant overfitting 
issues when training a neural network, and can lead to artificially high 
results should the network overfit to the majority class. To prevent these 
issues, the non-mortality cases were undersampled by saving only the 
first 150 non-mortality records with the required features. Under-
sampling was preferred to data augmentation as it ensured that only 
authentic data was used in training and testing this tool for critical 
healthcare applications. 
Following undersampling, the mortality rate in the 3-day and 7-day 
cohorts was 15.64% of 179 cases, while for 14-day NAIMS the mortality 
rate was 16.47% of 181 cases. Class weighting was used to further 
balance the dataset during training. Further statistical analysis of the 
cohorts used for training and testing each version are outlined in Ta-
bles 1 and 2 below, with 3-day, 7-day, and 14-day names hereafter 
denoted as NAIMS-3, NAIMS-7 and NAIMS-14 respectively. 
2.4. Neural network structure 
Hybrid networks have previously been used in mortality prediction 
for adults in one work that used extensive laboratory values and vital 
signs over a 48-h window, achieving reasonable AUROC of 0.834 [22]. 
While this shows good ability to distinguish between mortality and 
non-mortality cases, the dependence on long measurement windows and 
laboratory measurements limits the usability of the scheme for adult 
patients, let alone neonatal patients. 
As such, in our previous work [29] we proposed a hybrid CNN-LSTM 
neural network, which combined multiple convolutional layers with a 
bidirectional LSTM layer. This structure showed high success in pre-
dicting mortality for an adult patient cohort using 51 features describing 
demographics, heart rate, respiratory rate, blood pressure, temperature, 
and blood oxygen saturation. Based on the success of the model pro-
posed in our previous work, in this work we propose a shallower 
Fig. 1. Boxplots illustrating the distribution of LOS within the data.  
Table 1 
Characteristics of patient cohort for NAIMS-3 and NAIMS-7.  




Died (n = 28) 
Average and range of 
birthweights (kg) 




Female 77 (43.02%) 71 (47.02%) 6 (21.43%) 
Gestational age at birth (weeks) 
≤ 24 16 (8.94%) 5 (3.31%) 11 (39.29%) 
25-28 22 (12.29%) 14 (9.27%) 8 (28.57%) 
29-32 15 (8.38%) 13 (8.61%) 2 (7.14%) 
33-36 87 (48.60%) 85 (56.29%) 2 (7.14%) 
≥37 39 (21.79%) 34 (22.52%) 5 (17.86%)  
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CNN-LSTM hybrid neural network, illustrated in Fig. 2, featuring a 
reduced hybrid structure of a single convolutional layer and single 
bidirectional LSTM layer. As the scheme proposed in this work has 
substantially fewer inputs than our previous work, the shallower and 
more efficient structure was sufficient to achieve strong performance. 
The hybridisation of these two NN types combines the benefits of 
both. CNNs are well known for their ability to identify important fea-
tures, while LSTM networks are well known for their ability to 
remember previous data in the sequence. These attributes are important 
in health applications, where the most important features are often not 
known. Deeper networks were trialled, however no improvement in 
performance was seen as a result of adding further layers. As such, the 
shallow network was used for maximum computational efficiency. 
Our proposed NAIMS network uses the 17-feature vector outlined in 
the previous subsection as the input. This input vector is passed to the 
first layer, a temporal CNN layer with 128 hidden units that can be 












. (1)  
where yij is the jth output feature map from the ith layer. The term wijn, 
denotes the nth weight of the jth output feature map from the (i − 1)th 
layer, with n = 1, …, N. The bias term bj is the jth bias term of the ith 
layer. Weights and biases are updated during training using the Adam 
optimization algorithm. The outputs of the (i − 1)th layer are denoted as 
x(i− 1)m represents the outputs of the (i − 1)th layer. Finally, the convo-
lution operation itself is denoted by the asterisk symbol (*). 
The temporal CNN layer is then followed by a temporal average 
pooling layer, with pool and stride sizes of 2. This operation steps 
through the output of the CNN layer and takes the average of each pool. 
This results in a downsampled output, which aids in improving network 
efficiency and the prevention of overfitting. The addition of dropout 
layers was found to not improve the performance of the network, and 
thus only pooling was used to reduce the dimensionality of the layers. 
The output from the pooling layer is then passed to a bidirectional 
LSTM (BiLSTM) layer with 128 hidden units. The mathematical struc-
ture of the layer is shown in Eqs. (2)–(7). As the layer is bidirectional, the 
data is passed through this mathematical process in both original and 
reversed orders. The benefit of bidirectionality is that the layer can learn 
from both past and future values in the sequence. 
c̃t = tanh(wc[ a(t− 1), xt] + bc) (2)  
ft = σ
(
wf [ a(t− 1), xt] + bf
)
(3)  
ut = σ(wu[ a(t− 1), xt] + bu) (4)  
ot = σ(wo[ a(t− 1), xt] + bo) (5)  
ct = ut • c̃t + ft • c(t− 1) (6)  
at = ot • tanh(ct) (7)  
where weights are indicated by wc, wf, wu and wo, respectively. Biases 
are indicated by bc, bf, bu and bo, respectively. Again, biases and weights 
are updated using the Adam optimization algorithm. Outputs of the 
previous layer are denoted as a(t− 1), while xt is the input to time t. 
Table 2 
Characteristics of patient cohort for NAIMS-14.  




Died (n = 30) 
Average and range of 
birthweights (kg) 




Female 79 (43.65%) 71 (47.02%) 8 (26.67%) 
Gestational age at birth (weeks) 
≤ 24 16 (8.84%) 5 (3.31%) 11 (36.67%) 
25-28 24 (13.26%) 14 (9.27%) 10 (35.72%) 
29-32 15 (8.29%) 13 (8.61%) 2 (6.67%) 
33-36 87 (48.07%) 85 (56.29%) 2 (6.67%) 
≥37 39 (21.55%) 34 (22.52%) 5 (6.67%)  
Fig. 2. Neural network structure for NAIMS.  
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Equations (6) and (7) are the updated cell state and layer output 
respectively. Element-wise multiplication is denoted by ’•’, while σ is 
the sigmoid activation function. The final layer of NAIMS is a densely- 
connected node utilizing signmoid activation. Where the result of this 
activation is ≥ 0.5, the patient is predicted to die within the 3-day, 7- 
day, or 14-day window of the respective networks. Conversely, a result 
<0.5 indicates survival for that period. 
2.5. Training & testing the algorithms 
The NAIMS network was trained using stratified k-fold cross- 
validation with 5 folds, a method that splits data in 5 different ways 
while ensuring consistent ratios of the positive to negative cases in each 
split. Data was split randomly, with each record used as part of the 
testing set in only one of the five folds. Results obtained via cross- 
validation provide a more realistic view of the network performance. 
Due to using five folds for cross-validation, 20% of the data was used for 
testing in each fold, and thus remained unseen to the network while 
training for that fold. For training and validation, 60% and 20% of the 
data were used, respectively. 
It is worth noting that while 10-fold cross-validation is more com-
mon in the literature, it utilizes only 10% of data for testing per fold. 
Given the small size of this dataset and low representation of mortality 
cases, this would lead to extremely few mortality cases being included in 
testing. Thus, 5-fold was chosen to increase the number of cases - 
particularly mortality cases - used in each testing run to better assess the 
performance of the network. 
The unbalanced dataset was also accounted for when setting weights 
for training. Even after undersampling the non-mortality cases, mor-
tality occurred in only 16.47% of cases. To prevent overfitting to the 
majority case of non-mortality, heavier weightings were placed on the 
importance of learning the mortality case until their relative impor-
tances were roughly equivalent. This ensured that the network would 
consider accurate prediction of the death and survival cases as equally 
important, which is essential to prevent overfitting to either case. 
For each of the five folds, NAIMS was trained for 75 epochs with a 
single batch encompassing all training samples and with binary cross- 
entropy used as the loss function. This combination was found to yield 
the best results, with Fig. 3a–c illustrating training and validation loss 
over the 75 epochs for one fold of each NAIMS model. Each of these plots 
shows a decrease in validation loss corresponding to the decrease in 
testing loss, illustrating that the models are capable of generalizing to 
new data. 
As AUROC quantifies the ability of a network to distinguish between 
mortality and non-mortality cases, it was considered as the primary 
method for evaluating network performance. As such, the training and 
validation AUROC was also assessed to determine the goodness of fit for 
each model. As is shown in Fig. 4a–c, the validation AUROC steadily rose 
along with the training AUROC. The close proximity and comparable 
trend of the training and validation lines show that the models gener-
alized well when applied to validation data, indicating that overfitting 
has not occurred. 
Overall, it is clear that the models fit well to the data and are capable 
of generalizing well to new data. During each fold, the weights that 
resulted in the lowest validation loss were used for testing. 
3. Results & discussions 
In analysing the performance of the NAIMS networks, the key metric 
considered was area under the receiver-operator curve (AUROC). 
AUROC is the most common metric used for analysing diagnostics tools, 
and is calculated from the receiver-operator curve (ROC). Higher 
AUROC values indicate stronger ability to distinguish between the 
mortality and non-mortality case. Fig. 5 plots the ROC curves for NAIMS- 
3, NAIMS-7 and NAIMS-14, with the AUROC shown in the legend. From 
this graph, it is clear that all schemes achieve good AUROCS, with that 
NAIMS-3 unsurprisingly achieving the best result. 
Area under the precision-recall curve (AUPRC) is also often consid-
ered, particularly where data is imbalanced and the predictive perfor-
mance on the positive cases is highly important. AUPRC is considered 
with respect to the performance of a baseline random classifier, which 
would vary in performance depending upon the imbalance of the data. 
The higher the AUPRC is above the random classifier, the better its 
ability to distinguish between the two classes. The precision-recall 
curves for all NAIMS schemes are shown in Fig. 6, with AUPRC values 
presented in the legend. This figure clearly shows that the AUPRC for 
NAIMS-3 is very strong, with NAIMS-7 and NAIMS-14 also performing 
quite strongly. Overall, this indicates that all three models are dis-
tinguishing well between mortality and non-mortality cases. 
The results obtained by NAIMS-3, NAIMS-7 and NAIMS-14 during 
the testing phase are further numerically summarised in Table 3. In 
addition to AUROC and AUPRC, several metrics were considered to 
evaluate the predictive accuracy. Overall accuracy (ACC), sensitivity or 
true positive rate (TPR), and specificity or true negative rate (TNR) were 
calculated for each version of NAIMS. TPR and TNR are useful metrics 
for an unbalanced data set, as they show the accuracy for the positive 
(mortality) and negative (survival) cases, respectively. This allows for 
analysis of the fit; if ACC, TPR and TNR are all similar values, then the 
network has fit equally well to both cases despite the imbalance of the 
data. 
As shown in Table 3, NAIMS-3 performed extremely strongly. 
NAIMS-3 achieved an excellent AUROC of 0.9336 with strong overall 
accuracy and highly similar performance on both the positive and 
negative classes, as shown by the TPR and TNR values. Both NAIMS-7 
Fig. 3. Training and validation loss over epochs for NAIMS networks.  
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Fig. 4. Training and validation AUROC over epochs for NAIMS networks.  
Fig. 5. ROCs for all NAIMS schemes.  
Fig. 6. Comparison of PRCs for all NAIMS schemes.  
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and NAIMS-14 also achieved good results, with strong AUROC values 
and reasonable accuracy. Unsurprisingly, NAIMS-3 was the strongest 
performer across all metrics. This is likely due to its shorter predictive 
window, as the patient is more likely to be showing signs of deteriora-
tion when mortality risk is assessed for a shorter window. Meanwhile 
NAIMS-14 had the lowest performance, likely due to the longer window. 
This trend further emphasises the need for continuous short-term mor-
tality risk assessment as an alternative or compliment to the single 
mortality assessment that is routinely performed at admission time in 
NICUs today. 
It is also worth noting that the models could readily be tuned to focus 
more heavily on predicting the mortality case, however this would lead 
to reduced predictive performance for the non-mortality case and thus 
an increase in false alarms. This leads to a risk of alarm fatigue, a well 
documented phenomenon in NICU and general hospital environments 
[34–36] wherein healthcare workers are overwhelmed by the large 
number of patient health alarms and thus become desensitized to them. 
Alarm fatigue leads to serious risk of missing significant alarms, which 
has previously lead to deaths in hospitals [35]. 
Conversely, the models could be tuned to focus on the non-mortality 
case; which would incidentally increase the model accuracy as mortality 
rate is relatively low in NICU environments. However, identifying pa-
tients at risk of mortality is more critical than identifying patients who 
will survive, as the former group will require stronger intervention to 
maximise their chances of recovery. As such, it is preferable to obtain a 
lower accuracy with higher sensitivity to mortality cases and strong 
ability to distinguish between the two classes. Overall, NAIMS was 
designed to offer a balance between minimising false alarm fatigue 
whilst also maximising the number of true mortality risks identified. 
3.1. Feature importances 
An important factor for the adoption of artificial intelligence tools 
into clinical environments is the interpretability and explainability of 
the results [37–39]. One common method for interpreting the results of 
neural networks is SHAP (SHapley Additive exPlanations) [40], which 
involves the calculation of feature importances for each feature in each 
record when making a prediction. These can then be used to assess how a 
model makes predictions both on a global level and on a local level, with 
Fig. 7a–c illustrating the global perspective for NAIMS-3, NAIMS-7, and 
NAIMS-14. 
In Fig. 7a–c, each data point represents the SHAP value of a partic-
ular feature as it contributes to the output of one record. The x-axis 
indicates the impact on the model output; that is, whether the concerned 
feature pushed the prediction towards non-mortality (negative) or 
mortality (positive). The colour scale indicates whether the value of a 
particular feature was low (blue) through to high (red) compared to all 
other instances of that feature. 
From this global perspective, it is possible to interpret which features 
had the greatest impact on patient outcome. For example, a low median 
RR (denoted as RR_Med) is shown to have had a strong influence on 
predicting a mortality outcome across all three windows. Meanwhile, a 
low final value for HR (denoted as HR_Last) pushed predictions towards 
non-mortality. There are some results that were unexpected, such as a 
high STD for HR influencing a non-mortality prediction. While high 
variability has been previously shown to be an indicator of clinical 
deterioration, it may also show patient improvement if vital signs are 
rapidly stabilised in response to treatment. This would be an interesting 
area for future research. 
In calculating the SHAP values, we also generated “force plots” for 
several local instances, which allow for inspection of how features in-
fluence individual predictions. Fig. 8a–b illustrate the force plots for two 
records in the database. 
Fig. 8a shows the force plot for a non-mortality record which was 
correctly predicted by NAIMS-3, while Fig. 8b shows a mortality record 
which was correctly predicted. Features in blue indicate features that 
pushed the prediction towards a non-mortality output, while red influ-
enced the prediction towards a mortality output. The width of the bars 
indicates the magnitude of the feature’s influence. As such, we can 
determine that the features of last HR and RR (denoted as HR_Last and 
RR_Last, respectively) had the largest influence towards the non- 
Table 3 
Results obtains by NAIMS, presented as the average across the 5 folds with 
standard deviation in parentheses.  
Scheme ACC (%) TPR TNR AUROC AUPRC 
NAIMS-3 86.81 0.8710 0.8675 0.9336 0.8397  
(7.88) (0.0726) (0.0941) (0.0337) (0.0356) 
NAIMS-7 80.33 0.8125 0.8013 0.8804 0.7207  
(5.74) (0.0568) (0.0787) (0.0471) (0.1511) 
NAIMS-14 73.77 0.7500 0.7351 0.8470 0.6904  
(6.09) (0.0916) (0.0894) (0.0259) (0.0824)  
Fig. 7. SHAP summary plots for NAIMS networks.  
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mortality prediction in Fig. 8a and the mortality prediction in Fig. 8a. 
Local models such as these SHAP force plots could readily be used by 
clinicians to better interpret the outputs of the NAIMS network, which 
would aid in building trust in the model. 
Overall, SHAP analysis serves to illustrate the global and local per-
formance of the NAIMS model. The figures presented in this subsection 
clearly illustrate the influence that different features had on decision- 
making across the entire dataset, as well as highlighting how decisions 
were made in several local samples. 
3.2. Comparison to previous works 
In this section, we compare the results achieved by the NAIMS 
schemes to works presented in the literature. Table 4 compares the 
AUROCs of recent works, and includes descriptions of the features and 
measurement windows considered in each of the included works. The 
majority of previous works did not include ACC, TPR, TNR and/or 
AUPRC values in their analyses, so these have been excluded from the 
table. 
The results presented in Table 4 indicate that NAIMS-3 outperforms 
all previous works in the literature, achieving a significantly higher 
AUROC than all previous works. This high-performing network also has 
several other advantages over existing schemes, including the ability to 
perform mortality risk assessment based on any 12-h window of data 
during the patient’s stay. 
NAIMS-7 performs comparably to previous works, outperforming 
multiple schemes. NAIMS-14 performs comparably to the work pre-
sented by Houweling et al. [15], however does not perform as strongly 
as much of the literature. It is likely that access to additional training 
data would improve the performance of all NAIMS networks, and indeed 
this would be the next step required to work towards implementation of 
these schemes in real healthcare environments. 
While the proposed NAIMS networks depend upon more features 
than some previous works, 14 of the 17 features are easily derived from 
temporal HR and RR data. Conversely, several works [15,17] depend on 
variables that are completely distinct from each other and thus require 
more extensive acquisition and calculation. Furthermore, the work 
presented by Houweling et al. [15] depends upon subjective metrics 
assessing the baby’s appearance, rather than on tangiable measure-
ments. In the work presented by Jaskari et al. [18] only 14 variables are 
directly mentioned, however the dependence on SNAP-II and SNAPPE-II 
introduce many additional dependencies. Of the previous works 
included in Table 4, only the scheme presented by Jaskari et al. [18] 
could be updated on an ongoing basis during the patient stay. All other 
works depend on variables that are static and are measured immediately 
post-birth. 
Another significant advantage of all NAIMS schemes is the ability to 
be updated regularly and automatically, which allows for easier iden-
tification of trends in the patient’s health. Sex and birthweight are 
determined at birth, and gestational age could be automatically updated 
as the baby ages. HR and RR statistical values can be automatically 
calculated from monitoring equipment, or from manual data entries 
made by healthcare staff. Meanwhile, the only other scheme in the 
literature that is designed in such a way that mortality risk could be 
updated during the stay [18] still depends upon variables that would 
realistically make this challenging. Namely, it depends upon SNAP-II 
and SNAPPE-II scores which introduce a direct dependency on param-
eters such as PO2/FiO2, base excess, and urine output. Such parameters 
Fig. 8. Force plots for individual predictions made by the NAIMS-3 network.  
Table 4 





Description of Features Data Acquisition Window Algorithm Type AUROC 
Cooper [19] 10,051 284 Birth characteristics, laboratory test results, 
treatments received, existing conditions 
Varied - all available data from the 
patient stay used 
Superlearner (14 ML 
algorithms) 
0.91 
Podda [17] (Best 
Model) 
29,557 12 Birth characteristics, demographics, existing 
conditions, treatments received, maternal 
characteristics, maternal treatments received 
Varied - used maternal health pre- 
birth, plus measurements from the first 







51,374 10 Birth characteristics, maternal characteristics, 
condition of the baby by visual inspection 
Varied - some information obtained 
pre-birth and during birth, plus 5 min 
post-birth 
Logistic regression 0.85 
Medvedev [16] 
(UK Cohort) 
110,176 3 Birth weight, admission oxygen saturation, highest 
respiratory support within 24 h 
24 (from admission) Logistic regression 0.8903 
Medvedev [16] 
(Gambia Cohort) 
550 3 Birth weight, admission oxygen saturation, highest 
respiratory support within 24 h 
24 h Logistic regression 0.8082 
Jaskari [18] (Best 
Model) 
977 14 Vital signs, demographics, SNAP-II and SNAPPE-II 
scores 
36 h Random Forest 0.922 
NAIMS-3 179 17 Gestational age, birthweight, sex, vital signs 12 h (any window) CNN-LSTM 0.9336 
NAIMS-7 179 17 Gestational age, birthweight, sex, vital signs 12 h (any window) CNN-LSTM 0.8804 
NAIMS-14 181 17 Gestational age, birthweight, sex, vital signs 12 h (any window) CNN-LSTM 0.8470  
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are substantially more complex to measure than vital signs, and thus 
would introduce a higher burden on healthcare workers. 
Compared to previous works using hybrid neural networks to predict 
mortality risk in other populations, NAIMS performs strongly. Two 
works have previously considered CNN-LSTM networks for mortality 
prediction in adults. In Ref. [22], a deep CNN-LSTM is used to predict 
mortality from 37 laboratory values and vital signs, achieving an 
AUROC of 0.836. Meanwhile, our own previous work employed a 
CNN-LSTM with multiple CNN layers to predict mortality from 51 fea-
tures describing demographics and vital signs, with the strongest model 
achieving an AUROC Of 0.884. Comparatively, NAIMS is the shallowest 
CNN-LSTM model, has the fewest input features, and achieves an 
AUROC of up to 0.9336. The results of this work clearly demonstrate 
that a well-designed hybrid neural network with carefully selected 
features is suitable for a neonatal patient cohort, while previous works 
validate their use on adult patient cohorts. 
3.3. Limitations 
This work serves as a pilot study on the use of CNN-LSTM networks to 
predict mortality risk from basic demographics and vital signs. There are 
several limitations that must be acknowledged. The primary limitation is 
the small quantity of mortality data. While MIMIC-III is perhaps the 
largest open-access database for clinical research, very few NICU stays 
resulted in mortality. Prior works have had access to larger databases, 
although it is worth noting that the parameters included in those data-
bases were vastly different than those included in this work. While this 
pilot study shows highly promising results, further validation on a larger 
database would be required to conclusively prove the performance of 
our proposed NAIMS scheme. 
The high imbalance in the available dataset also in resulted in a need 
to perform undersampling and class weighting to enhance the ability of 
the network to learn from the data. This reduced the size of the non- 
mortality dataset. While necessary in this context, it would be prefer-
able to obtain larger quantities of data in both classes so that data 
balancing could be performed whilst maintaining a large database. 
In our future work, we aim to address these limitations by pursuing 
partnerships with local hospitals to clinically validate the NAIMS tool on 
large and diverse patient populations. 
4. Conclusion 
In this work, we have proposed the NAIMS shallow hybrid neural 
network structure that utilizes temporal convolution, pooling, and long 
short-term memory layers. NAIMS was then trained and tested for pre-
dicting mortality risk within the following 3, 7, and 14 day periods, 
resulting in NAIMS-3, NAIMS-7, and NAIMS-14, respectively. 
It was shown that our NAIMS schemes perform well when compared 
to existing schemes in the literature. In particular, NAIMS-3 outperforms 
all works in the literature, highlighting the benefit of shorter-term 
mortality risk assessment. All NAIMS scores can be recalculated regu-
larly and automatically, allowing for ongoing analysis of the patient’s 
condition during the NICU stay. 
Furthermore, NAIMS uses a short, 12-h window of temporal data to 
make its predictions, allowing the first prediction to be made within half 
a day of admission, without needing knowledge of maternal condition 
prior to birth. NAIMS also depends only upon simple features that are 
readily available in the NICU environment already. This simplicity en-
ables regular and automatic recalculation of mortality risk during the 
stay, which in turn enables healthcare workers to monitor a patient’s 
health trends and response to any treatments. 
As a result of these benefits and the strong ability to distinguish 
between mortality and non-mortality cases, we suggest that our NAIMS 
schemes are suitable for use in predicting mortality risk in NICU envi-
ronments. In our own future work, we aim to take these algorithms to 
clinical trials to further validate and improve the NAIMS schemes in 
terms of accuracy and usability. Additionally, we aim to conduct 
research into the prediction of other outcomes in NICU environments, 
such as the onset of sepsis and patient length of stay. 
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